diphenyldiselenide has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, C; Feng, H; Huo, D; Liang, W; Wang, D; Wang, H; Wang, S; Wang, X; Wang, Y; Yang, Y; Zhang, C | 1 |
1 other study(ies) available for diphenyldiselenide and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Diphenyl diselenide protects motor neurons through inhibition of microglia-mediated inflammatory injury in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Benzene Derivatives; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Female; Humans; Inflammation Mediators; Male; Mice; Mice, Transgenic; Microglia; Motor Neurons; Neuroprotective Agents; Organoselenium Compounds; Superoxide Dismutase-1 | 2021 |